VNN2 and COVID-19: A loss of VNN2 severely compromises HSC engraftment/reconstitution in vivo.21 Higher proportions of CD16+ monocytes after MSC infusion were found in the COVID-19 patients and similarly increased monocytes/macrophages were also found in MSC-LPS-treated mice with lung injury.